The Bioavailability of Mycoprotein

Availability of Mycoprotein Clinical Trial

Official title:

The Bioavailability of Mycoprotein

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04233411
• Other study ID #: 157758
• Status: Completed
• Phase: N/A
• Start date: January 2016
• Est. completion date: January 2018

Study information

• Verified date: January 2020
• Source: University of Exeter
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: January 2018
• Est. primary completion date: August 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Healthy and aged 18-40 y

• BMI between 18 and 30

Exclusion Criteria:

• On medication

• Family history of metabolic disease

• Diagnosed with any metabolic or cardiovascular conditions

• BMI < 18 or > 30

Related Conditions & MeSH terms

• Availability of Mycoprotein

Intervention

Other:
• Mycoprotein ingestion

Locations

Country	Name	City	State
United Kingdom	Sport & Health Sciences	Exeter	Devon

Sponsors (1)

Lead Sponsor	Collaborator
University of Exeter

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plasma total amino acid concentrations		4 hours